| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $16.9M | -11.1% |
| SG&A Expense | $12.8M | +11.6% |
| Operating Income | -$29.7M | +2.5% |
| Net Income | -$29.3M | +3.4% |
| EPS (Basic) | -$0.63 | +31.5% |
| EPS (Diluted) | -$0.63 | +30.8% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $6.1M | -43.1% |
| Inventory | $1.1M | — |
| Current Assets | $8.5M | -26.8% |
| Total Assets | $9.4M | -28.9% |
| Current Liabilities | $5.9M | +18.5% |
| Total Liabilities | $6.0M | +12.1% |
| Stockholders' Equity | $3.4M | -56.4% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$26.2M | -5.1% |
| Capital Expenditures | $64K | -39.0% |
| Investing Cash Flow | -$64K | -100.4% |
| Financing Cash Flow | $21.6M | +854.9% |
| Free Cash Flow | -$26.2M | -4.9% |